Superconductor Technologies EBITDA margin
Qual é o EBITDA margin de Superconductor Technologies?
O EBITDA margin de Superconductor Technologies Inc. é -1,472.55%
Qual é a definição de EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin de empresas na Setor Technology em NASDAQ em comparação com Superconductor Technologies
Empresas com ebitda margin semelhantes a Superconductor Technologies
- Cullen Resources tem EBITDA margin de -1,487.03%
- TALI Digital tem EBITDA margin de -1,481.92%
- Cyprium Metals tem EBITDA margin de -1,479.01%
- Sharing Economy International I tem EBITDA margin de -1,477.42%
- Tortoise Infrastructure Corp tem EBITDA margin de -1,475.23%
- Intra-Cellular Therapies Inc tem EBITDA margin de -1,473.56%
- Superconductor Technologies tem EBITDA margin de -1,472.55%
- Faster Enterprises tem EBITDA margin de -1,469.20%
- NICO Resources Ltd tem EBITDA margin de -1,465.21%
- Neovasc Inc tem EBITDA margin de -1,458.22%
- Condor Petroleum tem EBITDA margin de -1,456.70%
- Nikola tem EBITDA margin de -1,434.15%
- Fate Therapeutics Inc tem EBITDA margin de -1,431.66%